EP Wealth Advisors LLC Boosts Holdings in STERIS plc (NYSE:STE)

EP Wealth Advisors LLC lifted its stake in STERIS plc (NYSE:STE) by 20.1% in the 4th quarter, Holdings Channel.com reports. The firm owned 1,011 shares of the medical equipment provider’s stock after buying an additional 169 shares during the quarter. EP Wealth Advisors LLC’s holdings in STERIS were worth $208,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of STE. Avalon Trust Co purchased a new position in shares of STERIS in the 4th quarter worth about $30,000. Human Investing LLC purchased a new position in shares of STERIS in the 4th quarter worth about $31,000. Anfield Capital Management LLC raised its position in shares of STERIS by 100.0% in the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock worth $37,000 after purchasing an additional 91 shares during the last quarter. Manchester Capital Management LLC raised its stake in shares of STERIS by 182.7% in the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock worth $44,000 after purchasing an additional 137 shares during the last quarter. Finally, Brown Brothers Harriman & Co. raised its stake in shares of STERIS by 66.7% in the fourth quarter. Brown Brothers Harriman & Co. now owns 220 shares of the medical equipment provider’s stock worth $45,000 after purchasing an additional 88 shares during the last quarter. Hedge funds and other institutional investors own 94.69% of the company’s stock.

Wall Street Analysts Forecast Growth

STE has been the subject of several recent analyst reports. JMP Securities restated a “market outperform” rating and issued a $265.00 price target on shares of STERIS in a research note on Thursday, April 10th. Stephens upgraded STERIS to a “strong-buy” rating in a research note on Thursday, May 1st. Needham & Company LLC restated a “hold” rating on shares of STERIS in a research note on Monday, April 7th. Finally, Piper Sandler boosted their price target on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research note on Monday, February 3rd. One equities research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $258.75.

STERIS Stock Down 1.9%

STERIS stock opened at $226.80 on Thursday. The stock has a market cap of $22.28 billion, a PE ratio of 48.15 and a beta of 0.96. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. STERIS plc has a one year low of $200.98 and a one year high of $248.24. The stock has a fifty day moving average of $223.49 and a 200 day moving average of $218.94.

STERIS (NYSE:STE) last posted its quarterly earnings data on Wednesday, May 14th. The medical equipment provider reported $2.74 EPS for the quarter, beating analysts’ consensus estimates of $2.58 by $0.16. STERIS had a return on equity of 13.91% and a net margin of 8.66%. The business’s revenue for the quarter was up 5.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.58 earnings per share. As a group, sell-side analysts predict that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 26th. Investors of record on Tuesday, June 10th will be given a dividend of $0.57 per share. This represents a $2.28 dividend on an annualized basis and a yield of 1.01%. The ex-dividend date is Tuesday, June 10th. STERIS’s dividend payout ratio (DPR) is presently 48.41%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.